Rankings
▼
Calendar
AMPH FY 2015 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$860M
FY 2015 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$252M
+19.5% YoY
Gross Profit
$77M
30.8% margin
Operating Income
-$7M
-2.7% margin
Net Income
-$3M
-1.1% margin
EPS (Diluted)
$-0.06
Cash Flow
Operating Cash Flow
$11M
Free Cash Flow
-$5M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$390M
Total Liabilities
$95M
Stockholders' Equity
$296M
Cash & Equivalents
$66M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$252M
$210M
+19.5%
Gross Profit
$77M
$51M
+50.9%
Operating Income
-$7M
-$18M
+61.6%
Net Income
-$3M
-$11M
+74.0%
← FY 2014
All Quarters
Q1 2016 →